Evaluation of the Nuclisens HIV-1 QT assay for quantitation of human immunodeficiency virus type 1 RNA levels in plasma.

@article{Segondy1998EvaluationOT,
  title={Evaluation of the Nuclisens HIV-1 QT assay for quantitation of human immunodeficiency virus type 1 RNA levels in plasma.},
  author={Michel Segondy and Thoai Duong Ly and Marc Lapeyre and Brigitte Mont{\`e}s},
  journal={Journal of clinical microbiology},
  year={1998},
  volume={36 11},
  pages={
          3372-4
        }
}
Nuclisens HIV-1 QT is a new version of the NASBA HIV-1 QT assay for quantitation of human immunodeficiency virus type 1 (HIV-1) RNA in plasma. The specificity of this assay was 100% in one laboratory and 99%-with nonrepeatability of the initial false positive-in another. The test was linear between 2.0 and 6.0 log RNA copies per ml. According to the input HIV-1 RNA concentration, accuracy varied from -0.11 to +0.10 log RNA copy per ml and precision varied from 0.66 to 0.14 log RNA copy per ml… CONTINUE READING

Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-7 OF 7 CITATIONS